495 related articles for article (PubMed ID: 8893899)
21. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer.
Ford C; Spitzer G; Reilly W; Adkins D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin versus cisplatin in ovarian cancer.
Alberts DS
Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
[TBL] [Abstract][Full Text] [Related]
24. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
25. One-hour paclitaxel in the treatment of non-small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
[TBL] [Abstract][Full Text] [Related]
26. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-30-S12-33. PubMed ID: 9331117
[TBL] [Abstract][Full Text] [Related]
28. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
[TBL] [Abstract][Full Text] [Related]
29. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer.
Ozols RF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):1-6. PubMed ID: 8643963
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
[TBL] [Abstract][Full Text] [Related]
32. Carboplatin and paclitaxel in ovarian cancer.
Ozols RF
Semin Oncol; 1995 Jun; 22(3 Suppl 6):78-83. PubMed ID: 7541158
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study.
ten Bokkel Huinink W; Veenhof C; Huizing M; Rodenhuis S; Helmerhorst T; Dubbelman R; Dalesio O; Beijnen J; Winograd B
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-31-S2-33. PubMed ID: 9045333
[TBL] [Abstract][Full Text] [Related]
34. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
Natale RB
Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
DeVore RF; Jagasia M; Johnson DH
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
Choy H; Akerley W; Safran H; Graziano S; Chung C
Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer.
Paccagnella A; Favaretto A; Oniga F; Ossana L
Semin Oncol; 1996 Dec; 23(6 Suppl 16):76-9. PubMed ID: 9007128
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel in salvage therapy for germ cell tumors.
Motzer RJ
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
[TBL] [Abstract][Full Text] [Related]
39. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysis.
Neijt JP; Engelholm SA; Witteveen PO; Tuxen MK; Sørensen PG; Hansen M; Hirsch F; Sessa C; de Swart C; van Houwelingen HC; Lund B; Hansen SW
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-36-S15-39. PubMed ID: 9346220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
